rethinkTHC Search
Menu
Study breakdown

CBD Reduced Bone Loss from Gum Disease in Rats

Animal StudyPreliminary evidence
The takeaway

Daily CBD treatment reduced alveolar bone loss in rats with experimentally induced periodontal disease by suppressing RANKL/RANK expression and pro-inflammatory cytokines.

Read this if you are interested in how CBD might affect gum disease and bone health.

CBD reduced bone loss and inflammatory markers in rat gum disease model

What the researchers found

Researchers induced periodontal disease in rats using ligatures around the lower first molars and treated them with CBD (5 mg/kg daily) or vehicle for 30 days.

CBD-treated animals showed significantly less alveolar bone loss compared to untreated animals with periodontal disease.

The protective effect was associated with lower expression of RANKL/RANK, molecules that drive bone resorption. CBD-treated gingival tissue also showed decreased neutrophil migration and reduced levels of the pro-inflammatory cytokines IL-1beta and TNF-alpha.

Why it matters

Periodontal disease affects a large proportion of the global population and leads to tooth loss through inflammatory bone destruction. An anti-inflammatory compound that also reduces bone resorption could address both aspects of the disease process.

The numbers in context

CBD dose: 5 mg/kg daily for 30 days. CBD reduced alveolar bone loss, RANKL/RANK expression, neutrophil migration (MPO), IL-1beta, and TNF-alpha in gingival tissues.

How the study worked

Rat periodontal disease model using ligature placement around mandibular first molars. Three groups: healthy control, ligature + vehicle, ligature + CBD (5 mg/kg daily). After 30 days, bone loss was measured morphometrically, RANKL/RANK expression was assessed, and neutrophil migration (MPO) and cytokine levels (IL-1beta, TNF-alpha) were measured in gingival tissue.

What this study cannot tell us

Animal model of periodontal disease using ligatures is an artificial induction method. CBD was administered systemically rather than locally to the gums. Rat periodontal anatomy and healing differ from humans.

How to read the evidence

Animal study with a single CBD dose in an artificial periodontal disease model. Promising mechanism but far from clinical application.

When this study was published

Published in 2009. CBD and bone health research has continued to expand, though clinical evidence in dental settings remains limited.

The bigger picture

This study expanded CBD research into dental medicine. The dual action of reducing both inflammation and bone resorption through the RANKL/RANK pathway suggests CBD could be relevant to other conditions involving inflammatory bone loss, such as osteoporosis and rheumatoid arthritis.

Questions still open

  • Would locally applied CBD (in toothpaste or mouthwash) produce similar effects? Could CBD benefit human periodontal patients? Does CBD affect bone metabolism in other skeletal sites?

Common questions

Could CBD help with gum disease in humans?
This animal study showed promising results, but human clinical trials would be needed to determine whether CBD could benefit periodontal patients. The anti-inflammatory and bone-protective effects are plausible mechanisms but unproven in humans.
What is RANKL and why does it matter?
RANKL is a molecule that activates osteoclasts (bone-destroying cells). In periodontal disease, excessive RANKL leads to bone loss around teeth. By reducing RANKL expression, CBD may slow the bone destruction that leads to tooth loss.

Read the original research

Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats.

International immunopharmacology, 9(2), 216-22

Citation

Napimoga, Marcelo H; Benatti, Bruno B; Lima, Flavia O; Alves, Polyanna M; Campos, Alline C; Pena-Dos-Santos, Diego R; Severino, Fernando P; Cunha, Fernando Q; Guimarães, Francisco S. (2009). Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats.. International immunopharmacology, 9(2), 216-22. https://doi.org/10.1016/j.intimp.2008.11.010

Explore the wider topic